The Cabinet on Friday decided to use ¥1.4 trillion ($13 billion) in fiscal 2021 reserve funds, mainly for additional COVID-19 vaccine purchases as well as securing medicines for patients.
Of the amount, the government allocated about ¥841.5 billion to procure more vaccines and promote its inoculation rollout as the country struggles to contain a spike in virus infections driven by the highly contagious delta variant.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.